Hemophagocytic Lymphohistiocytosis in Autopsied Adults: Clinical, Laboratory and Immunohistochemical Evaluation for CD68 and CD57. Case Report and Literature Review

Autores

DOI:

https://doi.org/10.17921/2447-8938.2019v21n4p422-8

Resumo

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare, usually fatal and underdiagnosed autoimmune-activated disease. The present study aimed to perform a macroscopic, histopathological and immunohistochemical evaluation for CD68 and CD57 in organs of autopsied adults with HLH. A total of 604 autopsy reports were analyzed, and all the patients that filled the diagnostic criteria for HLH (n = 2) were selected. These patients were 18 and 37 years old. Were evaluated both clinical and autopsy reports and performed histopathological and immunohistochemical analysis of the liver and spleen. Both patients filled the diagnostic criteria for HLH, as well as presented common signs and symptoms of this disease, such as chills, abdominal pain, diaphoresis, and jaundice. Hemophagocytosis was observed in the spleen, bone marrow, and lymph nodes of the two patients at autopsy. Immunostaining in the liver and spleen of both patients was mainly severe for CD68, and predominantly mild for CD57, indicating a decrease in NKC numbers and an increase in the number of macrophages, respectively. This was the first study to evaluate CD57 and CD68 in autopsies of adults with HLH. Thus, more studies are required, not only to better elucidate the pathogenetic mechanisms involved in the secondary HLH, but also to disseminate the results in the clinical environment, contributing to the early diagnosis and treatment with consequent reduction of mortality rate.

 

Keywords: Autoimmune Diseases. Histiocytosis. Biomarkers.

 

Resumo

A Linfohistiocitose Hemofagocítica (HLH) é uma doença autoimune rara, geralmente fatal e subdiagnosticada. Este estudo tem como objetivo realizar avaliação macroscópica, histopatológica e imunohistoquímica para CD68 e CD57 em órgãos de pacientes adultos com HLH submetidos a autópsia. Um total de 604 laudos de autópsias foram analisados e todos os pacientes que preencheram os critérios diagnósticos para HLH (n = 2) foram selecionados. Esses pacientes tinham 18 e 37 anos de idade. Foram analisados tanto os prontuários quanto os laudos de autópsia, bem como foram realizadas análises histopatológicas e imunohistoquímicas do fígado e baço dos pacientes. Ambos preencheram os critérios diagnósticos para HLH e apresentarem sinais e sintomas comuns da doença, como calafrios, dor abdominal, sudorese e icterícia. A hemofagocitose foi observada no baço, medula óssea e linfonodos dos dois pacientes na autópsia. A imunohistoquímica do fígado e do baço de ambos os pacientes demonstrou imunomarcação acentuada para CD68 e predominantemente discreta para CD57, que indicam diminuição do número de NKC e aumento do número de macrófagos, respectivamente. Este foi o primeiro estudo a avaliar o CD57 e CD68 em autópsias de adultos com HLH. Assim, mais estudos são necessários, não apenas para melhor elucidar os mecanismos patogenéticos envolvidos na HLH secundária, mas também para disseminar os resultados no ambiente clínico, contribuindo para o diagnóstico e tratamento precoces com consequente redução da taxa de mortalidade.

 

Palavras-chave: Doenças Autoimunes. Histiocitose. Biomarcadores.

Biografia do Autor

Márcus Otávio Silva de Campos Menêses, University of Uberaba, Undergraduate Medical Student. MG, Brazil.

University of Uberaba (UNIUBE), Undergraduate Medical Student

Renata Margarida Etchebehere, Federal University of Triângulo Mineiro, Pathology Department. MG, Brazil.

Federal University of Triângulo Mineiro (UFTM), Pathology Department. PhD.

Márcia Fernandes de Araújo, Federal University of Triângulo Mineiro, Pathology Department. MG, Brazil.

Federal University of Triângulo Mineiro (UFTM), Pathology Department. PhD.

Ana Cristina da Rocha Duque, Federal University of Triângulo Mineiro, Pathology Department. MG, Brazil.

Federal University of Triângulo Mineiro (UFTM), Pathology Department. PhD.

Denise Bertulucci Rocha Rodrigues, University of Uberaba Laboratory of Biopathology and Molecular Biology; and Federal University of Triângulo Mineiro, Cefores. MG, Brazil.

University of Uberaba (UNIUBE), Laboratory of Biopathology and Molecular Biology and Federal University of Triângulo Mineiro (UFTM), Cefores. PhD.

Sanívia Aparecida de Lima Pereira, University of Uberaba, Laboratory of Biopathology and Molecular Biology; and Federal University of Triângulo Mineiro, Cefores. MG, Brazil.

University of Uberaba (UNIUBE), Laboratory of Biopathology and Molecular Biology and Federal University of Triângulo Mineiro (UFTM), Cefores. PhD.

Referências

Mostaza-Fernández JL, Guerra Laso J, Carriedo Ule D, Ruiz de Morales JM. Hemophagocytic lymphohistiocytosis associated with viral infections: diagnostic challenge and therapeutic dilemma. Rev Clin Esp 2014;214(6):320-7. doi: 10.1016/j.rce.2014.03.009

Brito-Zerón P, Kostov B, Moral-Moral P, Martínez-Zapico A, Díaz-Pedroche C, Fraile G, et al. Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis. Mayo Clin Proc Inn Qual Out 2018;2(3):267-76. doi: 10.1016/j.mayocpiqo.2018.06.006

Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, et al. Association of Crohn’s disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. J Pediatr 2011;159(5):808-12. doi: 10.1016/j.jpeds.2011.04.045

Bordbar MR, Modarrezi F, Farazi Fard MA, Dastsooz H, Shakib Azad N, Faghihi MA. A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis. BMC Med Genet 2017;18(1):49. doi: 10.1186/s12881-017-0404-9

Brandão-Neto RA, Santana AN, Danilovic DLS, Bernardi FDC. A very rare cause of dyspnea with a unique presentation on a computed tomography scan of the chest: macrophage activation syndrome. J Bras Pneumol 2008;34(2):118-20. doi: 10.1590/s1806-37132008000200009

Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology 2009(1):127-31. doi: 10.1182/asheducation-2009.1.127

Tesi B, Bryceson YT. HLH: genomics illuminates pathophysiological diversity. Blood 2018;132(1):5-7. doi: 10.1182/blood-2018-05-845818

Janka GE, Lehmberg K. Hemophagocytic syndromes: an update. Blood Rev 2014;28(4):135-42. doi: 10.1016/j.blre.2014.03.002

Atteritano M, David A, Bagnato G, Beninati C, Frisina A, Iaria C, et al. Haemophagocytic syndrome in rheumatic patients. a systematic review. Eur Rev Med Pharmacol Sci 2012;16(10):1414-24.

Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL. A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 2014;13(11):1142-8. doi: 10.1016/j.autrev.2014.05.009

Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr. 2016;4:47. doi: 10.3389/fped.2016.00047

Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14(5):548-52. doi: 10.1097/00002281-200209000-00012

Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003;15(5):587-90. doi: 10.1097/00002281-200309000-00011

Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatr Int 2016;58(9):817-25. doi: 10.1111/ped.13064

Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of Macrophage Activation Syndrome. Front Immunol 2019;119(10):1-11. doi: 10.3389/fimmu.2019.00119

Hasselblom S, Linde A, Ridell B. Hodgkin's lymphoma, Epstein–Barr virus reactivation and fatal haemophagocytic syndrome. Curr Opin Rheumatol 2004;255(2):289-95. doi: 10.1046/j.0954-6820.2003.01249.x

Todaro J, Bollman PW, Heymann RE, Peres MFP, Santana Netto PV, Felix MM, et al. Hemophagocytic syndrome in a patient with marginal zone lymphoma and Sjögren’s syndrome. RBM 2013;70(1):7-10.

Amisha, Malik P, Pathania M, Rathaur VK, Kaeley N. Hemophagocytic lymphohistiocytosis as a diagnostic consideration of fever of unknown origin with pancytopenia and chronic liver disease. J Family Med Prim Care 2019;8(4):1504–1507. doi: 10.4103/jfmpc.jfmpc_190_19

Chiang SC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W, et al. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood 2013;121(8):1345-56. doi: 10.1182/blood-2012-07-442558

Ammann S, Lehmberg K, Zur Stadt U, Janka G, Rensing-Ehl A, Klemann C, et al. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire. Eur J Immunol 2017;47(2):364-73. doi: 10.1002/eji.201646686.

Fatima Z, Khan A, Tariq U, Sohail MS. Hemophagocytic lymphohistiocytosis: a case series. Cereus 2018;10(4): e2545. doi: 10.7759/cureus.2545

Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146(5):598-604. doi: 10.1016/j.jpeds.2004.12.016.

Prado R, Terreri MT, Len CA, Braga J, Hilário MO. Macrophage activation syndrome in patients with juvenile idiopathic arthritis. Rev Bras Reumatol 2004;44(5):378-82. doi: 10.1590/S0482-50042004000500012

Silva CAA, Silva CHM, Robazzi TCMV, Lolito APN, Mendroni Junior A, Jacob CMA, et al. Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. J Pediatr 2004;80(6):517-22. doi: 10.2223/JPED.1267

Janka GE. Hemophagocytic syndromes. Blood Rev 2007;21(5):245-53. doi: 10.1016/j.blre.2007.05.001

Lufti F, Patel A, Becker D, Shahid M, Shah K. Hemophagocytic lymphohistiocytosis (HLH) presenting as fever of unknown origin and acute liver failure. IDcases 2018;14: e00413. doi: 10.1016/j.idcr.2018.e00413

Abbas MW, Shamshad T, Ashraf MA, Javaid R. Jaundice: a basic review. Int J Res Med Sci. 2016;4(5):1313-9. doi: 10.18203/2320-6012.ijrms20161196

Dupas B, Gournay J, Frampas E, Leaute F, Le Borgne J. Anicteric cholestasis: imaging and diagnostic strategy. J Radiol 2006;87(4 Pt2):441-59. doi: 10.1016/s0221-0363(06)74026-4

Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, et al. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a european collaboration on acute decompensated heart failure: ELAN-HF score. Heart 2014;100(2):115-25. doi: 10.1136/heartjnl-2013-303632

Cavalcante MHL, Miná AAL. Hepatosplenomegaly. It’s not always kala-azar. Rev. Saúde Criança Adolesc 2011;3(1):70-5.

Ronchi Júnior I, Pietrovicz J, Nocera VB, Vasconcelos CN, Fouani, MM, Pedri, LE. Hemaphagocytic syndrome. case report. Rev Bras Clin Med 2011;9(5):382-8.

Kuczynski AP, Cantergiani HB, Saraiva Junior JD. Síndrome hemofagocítica secundária [Secondary hemophagocytic syndrome]. Pediatria 1998;20(2):142-5.

Vega J, Rodríguez Mde L, Goecke H, Santamarina M. Hemophagocytic syndrome after dney transplant in a patient with hereditary nephritis. Report of one case. Rev Med Chil 2013;141(4):519-24. doi: 10.4067/S0034-98872013000400014

Schettert IT, Cardinalli IA, Ozello MC, Vassalo J, Lorand-Metze I, Souza CA. Hemophagocytic syndrome: pitfalls in its diagnosis. Sao Paulo Med J 1997;115(5):1548-52. doi: 10.1590/S1516-31801997000500007

Meng Z, Zhang Y, Wei Z, Liu P, Kang J, Zhang Y, et al. High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection. BMC Gastroenterol 2017;17(1):6. doi: 10.1186/s12876-016-0558-5

Tuon FF, Gomes VS, Amato VS, Graf ME, Fonseca GHH, Lazari C, et al. Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop 2008;50(2):123-7. doi: 10.1590/S0036-46652008000200012

Izzedine H, Brocheriou I, Martinez V, Camous L, Guillemont MC, Deray G. Fever, nephrotic syndrome, and rapidly progressive renal failure. Kidney Int 2007;72(5):651-6. doi: 10.1038/sj.ki.5002298

Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999;2(4):360-6.

Chen JH, Fleming MD, Pinkus GS, Pinkus JL, Nichols KE, Mo JQ, et al. Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol 2010;34(6):852-67. doi: 10.1097/PAS.0b013e3181dbbb17

Mu J, Jin C, Chen Z, Li J. Fatal unexpected death due to familial hemophagocytic lymphohistiocytosis type 3. Forensic Sci Med Pathol 2018;14(3)372-6. doi: 10.1007/s12024-018-9986-6

Semberova J, Rychly B, Hanzelova J, Jakubikova J. The immune status in situ of recurrent tonsillitis and idiopathic tonsillar hypertrophy. Bratisl Lek Listy 2013;114(3):140-4.

Downloads

Publicado

2019-12-20

Como Citar

1.
Menêses MOS de C, Etchebehere RM, de Araújo MF, Duque AC da R, Rodrigues DBR, Pereira SA de L. Hemophagocytic Lymphohistiocytosis in Autopsied Adults: Clinical, Laboratory and Immunohistochemical Evaluation for CD68 and CD57. Case Report and Literature Review. J. Health Sci. [Internet]. 20º de dezembro de 2019 [citado 21º de novembro de 2024];21(4):422-8. Disponível em: https://journalhealthscience.pgsscogna.com.br/JHealthSci/article/view/6716

Edição

Seção

Artigos